Committee Members

Biography
Dr. Nada J Habeichi is an academic researcher from American University of Beirut. She has contributed to research in topic(s): Inflammation & Heart failure. She has an hindex of 3, co-authored 6 publication(s) receiving 29 citation(s). Previous affiliations of Nada J Habeichi include French Institute of Health and Medical Research & Université Paris-Saclay.

Biography
Dr. Ruggero Maria Santilli was born September 8, 1935) in Capracotta.[2] He studied physics at the University of Naples and earned his PhD in physics from the University of Turin, graduating in 1965.[2] He held various academic positions in Italy until 1967, when he took a position at University of Miami; a year later he moved to Boston University, and subsequently held visiting scientist positions at Massachusetts Institute of Technology and Harvard University.[1][2]
In September 1981, he established a one-man organization,[3] the Institute for Basic Research in Boston;[2] he told a reporter from St. Petersburg Times in 2007 that he left Harvard because scientists there viewed his work as “heresy”.[1]

Biography
Dr. Kwa is an academic with multiple high impact factor publications in chronic disorders (e.g. haematological malignancies, Friedreich’s ataxia and age-related macular degeneration) and epigenetics. She has undertaken extensive research investigating potential treatment and diagnostic strategies for various types of leukaemia.
She has made novel observations that low doses of selected epigenetic modifiers (i.e. histone-deacetylase inhibitors) in combination therapies can potentiate cytotoxicity in leukaemia cells resistant to conventional chemotherapeutic drugs. She has also identified the use of a unique monoclonal antibody as a drug-vehicle for targeted leukaemia therapy and diagnostic tool. In recent times, she has been testing the use of natural compounds with epigenetic properties in age-related macular degeneration. Her passion in exploring new and targeted therapeutic approaches with superior efficacy for the treatment of human diseases continues.
Her current role is Senior Lecturer and Course Director for the Bachelor of Health Science degree. Her teaching interests are in Research Methods, Pathology and Molecular Biology. she also welcomes enquiries from students interested in pursuing Honours and PhD degrees in the above research areas.

Biography
Dr. Saadia Kerdine-Römer has experience in Immunotoxicology in the field of Skin Allergy. She has been working for many years in the activation of dendritic cells by allergenic molecules. She demonstrated that haptens can be real danger signals. She has worked on the identification of new signaling pathways in immunity cells in response to haptens. Currently, she is working on the transcription factor Nrf2 and its link in the inflammatory response of skin allergic origin.